Sprycel Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Chronic Myeloid Leukemia (CML) and Rising Adoption of Targeted Therapies
The Sprycel market is estimated to be valued at US$ 5.68 billion in 2023 and is expected to exhibit a CAGR of 5.5% over the …